Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Commentary

Effective but inaccessible antiobesity medications: A call for sharing responsibility for improving access to evidence-based care

Bartolome Burguera, MD, PhD, Marcio L. Griebeler, MD and W. Timothy Garvey, MD
Cleveland Clinic Journal of Medicine November 2024, 91 (11) 671-676; DOI: https://doi.org/10.3949/ccjm.91a.24068
Bartolome Burguera
Chief, Medical Specialty Institute, Cleveland Clinic, Cleveland, OH; Chair, Department of Endocrinology and Metabolism, Cleveland Clinic, Cleveland, OH; Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Find this author on Cleveland Clinic
Marcio L. Griebeler
Department of Endocrinology and Metabolism, Cleveland Clinic, Cleveland, OH; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Find this author on Cleveland Clinic
W. Timothy Garvey
Associate Director, Department of Nutrition Sciences and the University of Alabama at Birmingham Diabetes Research Center, University of Alabama at Birmingham, Birmingham AL; Professor, University of Alabama at Birmingham, Birmingham AL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

    • View popup
    TABLE 1

    US list prices (monthly cost) of second-generation antiobesity medications compared with selected other countries

    United StatesSpainDenmarkNetherlandsUnited KingdomJapanCanadaDubai
    Semaglutide 2.4 mg$1,349$314$343$296$233$69$388$326
    Tirzepatide 10–15 mg$1,069$400$632$444$162$319$104$472
    • Information based on web searches, direct pharmacy pricing information, and reference 22.

PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 91 (11)
Cleveland Clinic Journal of Medicine
Vol. 91, Issue 11
1 Nov 2024
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Effective but inaccessible antiobesity medications: A call for sharing responsibility for improving access to evidence-based care
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Effective but inaccessible antiobesity medications: A call for sharing responsibility for improving access to evidence-based care
Bartolome Burguera, Marcio L. Griebeler, W. Timothy Garvey
Cleveland Clinic Journal of Medicine Nov 2024, 91 (11) 671-676; DOI: 10.3949/ccjm.91a.24068

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Effective but inaccessible antiobesity medications: A call for sharing responsibility for improving access to evidence-based care
Bartolome Burguera, Marcio L. Griebeler, W. Timothy Garvey
Cleveland Clinic Journal of Medicine Nov 2024, 91 (11) 671-676; DOI: 10.3949/ccjm.91a.24068
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • THE CONUNDRUM OF OBESITY TREATMENT
    • SHARED RESPONSIBILITIES: A CALL TO ACTION
    • SUBSTANDARD PRACTICES WITH POTENTIAL HARM
    • CLOSING THOUGHTS
    • DISCLOSURES
    • Acknowledgments
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Effective but inaccessible antiobesity medications
  • Google Scholar

More in this TOC Section

  • Respiratory virus season: Strategies for successful navigation
  • Matter of the heart: Prioritizing harm reduction in managing infective endocarditis associated with injection drug use
Show more Commentary

Similar Articles

Subjects

  • Endocrinology
  • Obesity

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire